Overview

A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
A Phase 1, Single-centre, Double-blind, Placebo controlled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants
Phase:
Phase 1
Details
Lead Sponsor:
Autifony Therapeutics Limited
Collaborator:
University of Manchester
Treatments:
Ketamine